Tackling large challenges collectively | MIT Know-how Evaluation


In regards to the audio system

Dr. Kizzmekia Corbett, Lead Scientist, COVID-19 mRNA Vaccine Improvement; Assistant Professor, Harvard T.H. Chan Faculty of Public Well being

Dr. Kizzmekia Corbett was the scientific lead of the Vaccine Analysis Heart’s coronavirus crew on the U.S. Nationwide Institutes of Well being the place she studied coronavirus biology and vaccine improvement. These 6 years of analysis led to the groundbreaking discovery {that a} stabilized model of a spike protein, which is discovered on the floor of all coronaviruses, could be a key goal for vaccines, remedies, and diagnostics. On the onset of the COVID-19 pandemic, she and her colleagues have been central to the event of the Moderna mRNA vaccine and the Eli Lilly therapeutic monoclonal antibody, each of which have been first to enter medical trials on the planet. In consequence, her work is having a considerable impression on ending the worst respiratory-disease pandemic in additional than 100 years. Dr. Corbett is now an assistant professor within the Division of Immunology and Infectious Ailments on the Harvard T.H. Chan Faculty of Public Well being, in addition to the Shutzer Assistant Professor at Harvard’s Radcliffe Institute of Superior Examine and an Affiliate Member of the Phillip T. and Susan M. Ragon Institute. Her work now extends past the speedy improvement of COVID-19 vaccines to the outlook of this pandemic and future viral pandemics.

Maybe simply as vital as her scientific accomplishments, Dr. Corbett has burst onto the general public stage because the face of a various and rising technology of gifted scientists who will remodel the world. She is a stellar science communicator, explaining the vaccine and the virus in extremely accessible methods to media shops, two U.S. presidents, and audiences across the globe.

Laurent Duvernay-Tardif, Graduate in Drugs; Tremendous Bowl Champion

Referred to as “essentially the most attention-grabbing man within the NFL”, Laurent Duvernay-Tardif is an eight-year NFL veteran, Tremendous Bowl champion, and the one energetic NFL participant with a medical diploma. Simply months after his Tremendous Bowl win with the Kansas Metropolis Chiefs — and within the midst of the COVID-19 pandemic — Duvernay-Tardif stepped away from soccer to hitch the medical entrance strains. From the unbelievable highs of successful the SuperBowl to the burnout of working as an orderly, Duvernay-Tardif shares his outstanding private story, talking to resiliency, management, and extra.

As plans for the 2020 NFL season ramped up, Duvernay-Tardif stepped away from the sport he beloved, changing into the primary participant of the 2020 NFL season to publicly opt-out. For the primary time in his outstanding profession, Duvernay-Tardif couldn’t reconcile his twin passions of soccer and drugs, and together with his crew’s Tremendous Bowl win solely months behind him, he discovered himself on the entrance strains of the pandemic, working in a long-term care facility in Quebec. Whereas engaged on the entrance strains, Duvernay-Tardif enrolled in Harvard’s T.H. Chan Faculty of Public Well being.

Juergen Eckhardt, SVP and Head, Leaps by Bayer

Juergen Eckhardt is SVP and Head of Leaps by Bayer, the impression funding unit of Bayer. The mission of Leaps is to put money into breakthrough applied sciences and disruptive enterprise fashions within the areas of healthcare and agriculture. Juergen has been a enterprise investor since 2002 and at present serves on the board of Joyn Bio, Dewpoint, Century, Khloris, Oerth Bio, Immunitas, eGenesis, and others. Beforehand, Juergen was a administration marketing consultant and Affiliate Companion with McKinsey & Co. and a member of McKinsey’s Healthcare Management Workforce. He started his profession as a radiologist on the College Hospital of Basel, Switzerland. Juergen obtained his M.D. from the College of Basel and his MBA from INSEAD in Fontainebleau, France.

Elizabeth Bramson-Boudreau

Elizabeth Bramson-Boudreau, CEO and Writer, MIT Know-how Evaluation

Elizabeth Bramson-Boudreau is the CEO and writer of MIT Know-how Evaluation, the Massachusetts Institute of Know-how’s impartial media firm.

Since Elizabeth took the helm of MIT Know-how Evaluation in mid-2017, the enterprise has undergone a large transformation from its earlier place as a revered however area of interest print journal to a broadly learn, multi-platform media model with a world viewers and a sustainable enterprise. Below her management, MIT Know-how Evaluation has been lauded for its editorial authority, its best-in-class occasions, and its novel use of impartial, authentic analysis to assist each advertisers and readers.

Elizabeth has a 20-year background in constructing and working groups at world-leading media corporations. She maintains a eager give attention to new methods to commercialize media content material to attraction to discerning, demanding customers in addition to B2B audiences.

Previous to becoming a member of MIT Know-how Evaluation, Elizabeth held a senior government function at The Economist Group, the place her management stretched throughout enterprise strains and included mergers and acquisitions; editorial and product creation and modernization; gross sales; advertising; and occasions. Earlier in her profession, she labored as a marketing consultant advising know-how companies on market entry and worldwide enlargement.

Elizabeth holds an government MBA from the London Enterprise Faculty, an MSc from the London Faculty of Economics, and a bachelor’s diploma from Swarthmore School.


Please enter your comment!
Please enter your name here